Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Daniel Clark is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/02/2024 | ELAN | Buy Now | Elanco Animal Health | $10.51 | 33.21% | Daniel Clark15% | → $14 | Initiates | → Market Perform | Get Alert |
| 12/02/2024 | IDXX | Buy Now | IDEXX Laboratories | $410.10 | 21.92% | Daniel Clark15% | → $500 | Initiates | → Outperform | Get Alert |
| 12/02/2024 | ZTS | Buy Now | Zoetis | $161.30 | 33.29% | Daniel Clark15% | → $215 | Initiates | → Outperform | Get Alert |
